跳至主要内容
临床试验/NCT02550899
NCT02550899已完成4 期

Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence

Karolinska Institutet0 个研究点目标入组 30 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
30
主要终点
Wexner overall score

研究概览

简要总结

A randomized study to evaluate the safety and effects of transanal submucosal polyacrylamide hydrogel injection therapy for anal incontinence.

详细描述

A prospective randomized study to assess the use of Bulkamid for anal incontinence using three different transanal injection techniques .

Patients with anal incontinence severity Wexner score >7. Standardised injection treatment at baseline. Clinical status and subjective symptom evaluation (Wexner score and FIQL) at baseline, 2 months, 6 months and 1 year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • informed consent, anal incontinence with Wexner score >10

排除标准

  • ino additional pregnancies, schedule for pelvic organ surgery within 1 year of treatment, current or previous pelvic organ cancer, insulin treated diabetes, inflammatory bowel disease

结局指标

主要结局

Wexner overall score

时间窗: 1 year

次要结局

  • FIQL overall score(1 year)
  • Adverse events(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Altman

Associate professor

Karolinska Institutet

相似试验